While CD34+ hematopoietic progenitor cells and unselected BM samples of healthy donors lack BCL11b expression, T-ALL patients showed an aberrant and highly heterogonous BCL11b expression pattern. This evidence concerns the gene BCL11B and acute lymphoblastic leukemia.